SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹0.55 Cr | ₹0.55 Cr | ₹0.55 Cr | ₹2.74 Cr | ₹0.83 Cr |
What is the latest Contingent Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹0.55 Cr |
Mar2023 | ₹0.55 Cr |
Mar2022 | ₹0.55 Cr |
Mar2017 | ₹2.74 Cr |
Mar2016 | ₹0.83 Cr |
How is Contingent Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.55 Cr | 0.00 | |
Mar2023 | ₹0.55 Cr | 0.00 | |
Mar2022 | ₹0.55 Cr | -79.96 | |
Mar2017 | ₹2.74 Cr | 231.80 | |
Mar2016 | ₹0.83 Cr | - |
Compare Contingent Liabilities of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,120.6 Cr | 1.3% | 9.9% | 103.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹435,407.0 Cr | 0.3% | 0.2% | 46% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,489.0 Cr | -2.7% | -0.1% | 58.9% | Stock Analytics | |
CIPLA | ₹117,443.0 Cr | -3% | -8.6% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,338.0 Cr | -0.1% | -3.4% | 7.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,244.9 Cr | 0.8% | 1.8% | 48.1% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | 1.3% |
9.9% |
103.9% |
SENSEX | 0.7% |
2.5% |
17% |
You may also like the below Video Courses